Who owns G50871905 - JAZZ PHARMACEUTICALS PLC - CALL based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

JAZZ PHARMACEUTICALS PLC - CALL Institutional Ownership

CUSIP G50871905 is the security identifier used in SEC filing datasets for G50871905 - JAZZ PHARMACEUTICALS PLC - CALL.

CUSIP: G50871905

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

What is CUSIP G50871905?
CUSIP G50871905 identifies G50871905 - JAZZ PHARMACEUTICALS PLC - CALL in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Open recent reporting periods for CUSIP G50871905:

As of 31 Dec 2025, 0 institutional investors reported holding shares of JAZZ PHARMACEUTICALS PLC - CALL.

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2025 Q4					$52,416,597	$170.00	0
2025 Q3					$16,853,736	$131.80	0
2025 Q2					$10,007,230	$106.12	0
2025 Q1					$13,776,603	$124.15	0
2024 Q4					$1,588,445	$123.11	0
2024 Q3	0	$0	-$273,000		$8,020,650	$111.35	0
2024 Q2	600	$273,000	+$273,000		$10,885,643	$106.73	1
2024 Q1					$11,524,170	$120.42	0
2023 Q4					$11,438,600	$123.00	0
2023 Q3					$16,024,136	$129.44	0
2023 Q2					$3,185,741	$123.97	0
2023 Q1					$5,193,782	$146.33	0
2022 Q4					$8,411,500	$159.31	0
2022 Q3					$26,832,000	$133.29	0
2022 Q2					$6,880,000	$156.02	0
2022 Q1					$6,304,000	$155.58	0
2021 Q4					$4,013,000	$127.38	0
2021 Q3					$7,338,000	$155.66	0
2021 Q2				$0	$11,067,000	$177.64	0
2021 Q1				$290,000	$30,129,000	$247.44	0
2020 Q4					$29,923,000	$165.05	0
2020 Q3					$13,594,000	$142.65	0
2020 Q2					$375,000	$5570.15	0
2020 Q1					$1,436,000	$5036.01	0
2019 Q4					$3,119,000	$14923.44	0
2019 Q3					$3,716,000	$6470.74	0
2019 Q2					$1,982,000	$7200.24	0
2019 Q1					$3,444,000	$7215.83	0
2018 Q4					$979,000	$12392.41	0
2018 Q3					$1,596,000	$8481.98	0
2018 Q2					$25,173,000	$172.31	0
2018 Q1	0	$0	-$1,049,000		$7,262,000	$151.00	0
2017 Q4	7,788	$1,049,000			$1,766,000	$134.66	1
2017 Q3					$9,206,000	$148.13	0
2017 Q2					$2,790,000	$155.56	0
2017 Q1					$36,877,000	$145.14	0
2016 Q4					$4,361,000	$111.80	0
2016 Q3					$16,294,000	$121.48	0
2016 Q2					$78,455,000	$141.31	0
2016 Q1					$43,113,000	$130.55	0
2015 Q4					$43,728,000	$140.56	0
2015 Q3					$12,575,000	$132.82	0
2015 Q2					$17,546,000	$176.07	0
2015 Q1					$18,370,000	$172.82	0
2014 Q4					$29,765,000	$163.72	0
2014 Q3					$30,555,000	$160.57	0
2014 Q2					$21,199,000	$147.01	0
2014 Q1					$37,818,000	$138.68	0